Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger
B
B
Knauf
W
W
Thiel
E
E
D015762:2-Chloroadenosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced / Q000188:drug therapy*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D003839:Deoxyadenosines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D003839:Deoxyadenosines; D007166:Immunosuppressive Agents; D015762:2-Chloroadenosine; D007168:IMP Dehydrogenase; D009173:Mycophenolic Acid; C055994:2-chloro-3'-deoxyadenosine